31 March 2025
VIVEbiotech celebrates 10 years of innovation in lentiviral vector manufacturing
A decade of growth, achievements, and a promising future ahead.
GMP CDMO focused on different stages of the process.
We work exclusively in lentivirus, offering comprehensive services.
Technical adaptation and timely slot availability for each project.
Compliance with EMA and FDA regulatory requirements.
in the US, Europe, Asia and Australia
in reactor since 2020
since 2018
exclusively to lentivirus production
combining young talent and experience
We are a Contract Development and Manufacturing Organization (CDMO) with over 40 biotech companies worldwide that have placed their trust in us.
Read moreVIVEbiotech is one of the only companies in the world specialized exclusively in lentiviral vectors. One of the things that sets us apart is our expertise not only in production but also virology, backed by a team of professionals with more than 30 years of experience.
Read more31 March 2025
A decade of growth, achievements, and a promising future ahead.
23 January 2025
We are overjoyed to announce that VIVEbiotech has been named the “CMO/CDMO of the...